FINWIRES · TerminalLIVE
FINWIRES

4DMedical to Acquire Austrian Medical AI Company Contextflow in Cash, Stock Deal; Shares Up 6%

By

4DMedical (ASX:4DX) signed a binding agreement to acquire Austria-based contextflow, a medical technology company specializing in lung cancer screening and advanced artificial intelligence-driven thoracic imaging, in a deal that includes upfront cash payments of about AU$18.6 million, according to a Monday Australian bourse filing.

The deal also includes 56,235 ordinary shares, plus an earn-out of up to 2.6 million zero-exercise-price options over two years subject to performance milestones

The company said the acquisition establishes an immediate European commercial and clinical platform, with contextflow retaining about AU$30.8 million in accumulated tax losses.

The acquisition introduces insurance reimbursement contracts in Germany and helps expand the company's CT:VQ product across the region, per the filing.

4DMedical's shares jumped nearly 6% in recent Monday trade.

Related Articles

Asia

Genrix Grants CQ Pharmaceutical Distribution Rights for Myeloma Drug in China, Hong Kong, Macau, Taiwan

Chongqing Genrix Biopharmaceutical (SHA:688443) granted C.Q. Pharmaceutical (SHE:000950) subsidiary Yaoyou Pharmaceutical exclusive development and distribution rights for the GR1803 drug across China and Hong Kong, Macau, and Taiwan.The agreement covers development such as clinical trials, research, and manufacturing, as well as sales, the filing said.The GR1803 velitumimumab drug is indicated for multiple myeloma, a rare form of blood cancer.Yaoyou will pay Genrix up to 600 million yuan in initial payment, listing milestone, and technology transfer milestone payments.Genrix will also be eligible to receive sales royalties of up to a minimum percentage of two digits.

SHA:688443SHE:000950
Asia

Xuan Wu Cloud's CFO Steps Down

Xuan Wu Cloud Technology's (HKG:2392) Chief Financial Officer Ge Ping resigned to devote more time to personal affairs effective May 31, according to a Friday Hong Kong bourse filing.

HKG:2392
Asia

Update: Xi'an Eswin Materials Technology to Invest Up to 40 Million Yuan in Glassmaker's Funding Round

Xi'an Eswin Materials Technology (SHA:688783) will invest up to 40 million yuan in a pre-A+ funding round for Zhuhai Yiyuan Technology, according to a Friday filing with the Shanghai bourse.Zhuhai Yiyuan Technology seeks to raise between 100 million yuan and 200 million yuan in a funding round.The glass manufacturer plans to use the proceeds for capacity expansion, equipment procurement, and technology upgrades.

SHA:688783